- $7.55bn
- $6.55bn
- $1.83bn
- 91
- 40
- 64
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 30th | 2023 December 29th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 968 | 988 | 1,435 | 1,611 | 1,830 |
Cost of Revenue | |||||
Gross Profit | 935 | 951 | 1,382 | 1,553 | 1,758 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 598 | 877 | 1,148 | 1,410 | 1,659 |
Operating Profit | 369 | 110 | 287 | 201 | 171 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 398 | 131 | 294 | 234 | 258 |
Provision for Income Taxes | |||||
Net Income After Taxes | 321 | 112 | 231 | 182 | 208 |
Net Income Before Extraordinary Items | |||||
Net Income | 321 | 112 | 231 | 182 | 208 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 321 | 112 | 231 | 182 | 208 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.02 | 0.352 | 0.717 | 0.562 | 0.646 |